News & Analysis as of

Public Offerings Early Stage Companies

Latham & Watkins LLP

Life Sciences Product Development Needs More Creative Fundraising

Latham & Watkins LLP on

The life sciences industry depended historically on public offerings for fundraising to support costs of developing therapeutic pharmaceutical and biologic products. The average cost of discovering and developing these...more

WilmerHale

2022 IPO Report

WilmerHale on

Across the board, despite the continuing pall cast by the COVID-19 pandemic, 2021 was a year of very strong IPO deal flow, although aftermarket performance fell well short in comparison to the prior year and broad market...more

Hogan Lovells

Hong Kong's Listing Regime – The Way Forward

Hogan Lovells on

With overwhelming market support, The Stock Exchange of Hong Kong Limited has concluded that Hong Kong's listing regime must be expanded to remain competitive amidst a changing global capital environment. ...more

Latham & Watkins LLP

Private equity in Italy: market and regulatory overview

Latham & Watkins LLP on

How do private equity funds typically obtain their funding? Private equity funds continued to have a diverse investor base in 2015. Although with a significant decrease from the 2014 figure of 68%, about 48% of the...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide